Article
Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cancer gene therapy - 1 Sept 1995
Cai D W, Mukhopadhyay T, Roth J A
Abstract excerpt
An anti-p53 ribozyme (catalytic RNA) designed to cleave the p53 pre-messenger RNA (mRNA) can efficiently reduce the level of endogenous mutant p53 mRNA. Retrovirus-mediated transduction of a hammerhead ribozyme (Rz5a) designed to cleave unspliced p53 RNA at codon 187 near the boundary of intron 5...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
